LZTR1 Gene: Leucine Zipper Like Transcription Regulator 1

A key regulator of RAS/MAPK signaling and tumor suppression, implicated in Noonan syndrome and glioblastoma.

Gene Information Card

Symbol LZTR1
Full Name Leucine Zipper Like Transcription Regulator 1
Gene Type Protein coding
Chromosomal Location 22q11.21
NCBI Gene ID 8216 ncbi.nlm.nih.gov/gene/8216
Ensembl ID ENSG00000100029
UniProt ID Q8N653
OMIM ID 600574
HGNC ID 6747
Aliases BTBD29, LZTR-1, SWNTS2

Description

LZTR1 encodes a protein containing BTB/POZ and Kelch domains, acting as a substrate adaptor for the CUL3 ubiquitin ligase complex. It negatively regulates the RAS/MAPK signaling pathway by promoting ubiquitination and degradation of RAS proteins. Loss-of-function mutations lead to RAS pathway hyperactivation, contributing to developmental disorders (Noonan syndrome) and tumorigenesis (glioblastoma, schwannomatosis).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Noonan syndrome Loss-of-function mutations impair RAS degradation, leading to increased RAS-MAPK signaling during development. ClinVar, OMIM #600574
Schwannomatosis 2 Germline LZTR1 mutations predispose to multiple schwannomas via RAS pathway dysregulation. OMIM #615670, ClinVar
Glioblastoma Somatic mutations and deletions of LZTR1 are recurrent in glioblastoma, promoting tumor growth. COSMIC, NCBI Gene
RASopathies LZTR1 alterations contribute to a spectrum of disorders with overlapping features of Noonan syndrome. OMIM, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 5.2 Low
Heart 3.8 Low
Lung 2.1 Low
Liver 1.5 Low
Kidney 2.9 Low
Cell Line Expression
Cell Line nTPM Notes
HEK 293 4.5 Embryonic kidney cell line
SH-SY5Y 6.1 Neuroblastoma cell line
U87MG 3.2 Glioblastoma cell line
HeLa 2.8 Cervical carcinoma cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.742C>T (p.Arg248*) Nonsense <0.1% in general population Loss of function; truncation of Kelch domain
c.517G>A (p.Gly173Arg) Missense Rare in Noonan syndrome Impaired substrate binding; dominant negative effect
c.1285C>T (p.Arg429Cys) Missense Somatic in glioblastoma Reduced ubiquitin ligase activity
Deletion of 22q11.21 Copy number loss Recurrent in glioblastoma Complete loss of LZTR1 expression
Mutation functional classification

Loss of Function (LOF)

Most common mechanism; nonsense, frameshift, or splice-site mutations lead to truncated or absent protein, reducing RAS ubiquitination and increasing MAPK signaling.

Gain of Function (GOF)

Not well documented; some missense variants may alter substrate specificity but evidence is limited.

Dominant Negative (DN)

Missense mutations (e.g., p.Gly173Arg) can interfere with wild-type LZTR1 function, impairing CUL3 complex assembly.

Gene Ontology (GO)

• ubiquitin ligase complex • protein ubiquitination
• negative regulation of Ras protein signal transduction • BTB domain binding
• Kelch repeat binding

Pathways

• RAS/MAPK signaling
• CUL3-mediated ubiquitination
• Receptor tyrosine kinase signaling

Protein Summary

The LZTR1 protein (UniProt Q8N653) contains an N-terminal BTB/POZ domain and six C-terminal Kelch repeats. It functions as a substrate adaptor for the CUL3-RING E3 ubiquitin ligase complex, targeting RAS proteins for proteasomal degradation. This regulation is critical for controlling cell proliferation and differentiation. Mutations that disrupt LZTR1 function lead to RAS pathway hyperactivation, contributing to developmental syndromes and cancer.

Related Products

Product name Cat.No. Species Gene ID
LZTR1 Knockout HEK293 Cell Line EDJ-KQ2904 Human 8216 Details Get a Quote
LZTR1 Knockout A-549 Cell Line EDJ-KQ23986 Human 8216 Details Get a Quote
LZTR1 Knockout HCT 116 Cell Line EDJ-KQ23987 Human 8216 Details Get a Quote
LZTR1 Knockout HeLa Cell Line EDJ-KQ23988 Human 8216 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: